Mark David

5.6k total citations · 4 hit papers
26 papers, 4.6k citations indexed

About

Mark David is a scholar working on Molecular Biology, Immunology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Mark David has authored 26 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Mark David's work include RNA Interference and Gene Delivery (4 papers), RNA and protein synthesis mechanisms (4 papers) and Air Quality and Health Impacts (3 papers). Mark David is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), RNA and protein synthesis mechanisms (4 papers) and Air Quality and Health Impacts (3 papers). Mark David collaborates with scholars based in United States, United Kingdom and Switzerland. Mark David's co-authors include Daniel A. Rappolee, Zena Werb, Michael J. Banda, Richard M. Schultz, Carol A. Brenner, Ernest S. Kawasaki, Alice Wang, Martha Ladner, Alice M. Wang and Roy M. Harrison and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Mark David

26 papers receiving 4.3k citations

Hit Papers

Wound Macrophages Express TGF-α and Other Growth Factors ... 1984 2026 1998 2012 1988 1988 1985 1984 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark David United States 19 1.9k 1.5k 638 583 430 26 4.6k
Andrew Saxon United States 42 921 0.5× 2.2k 1.5× 421 0.7× 251 0.4× 1.6k 3.7× 104 6.0k
Shuli Li United States 46 2.1k 1.1× 1.2k 0.8× 1.2k 1.9× 552 0.9× 132 0.3× 239 6.9k
James J. Lee United States 62 1.5k 0.8× 4.4k 2.9× 2.7k 4.2× 313 0.5× 340 0.8× 200 11.5k
Huan Zhang China 38 2.1k 1.1× 577 0.4× 289 0.5× 211 0.4× 210 0.5× 222 4.6k
Radovan Borojević Brazil 45 2.3k 1.2× 849 0.6× 467 0.7× 313 0.5× 46 0.1× 291 8.9k
Feng Zhang China 30 1.5k 0.8× 464 0.3× 298 0.5× 601 1.0× 138 0.3× 225 4.2k
Mark A. Vickers United Kingdom 40 1.0k 0.5× 1.1k 0.8× 781 1.2× 602 1.0× 195 0.5× 108 5.1k
Xiaomin Zhang China 41 3.0k 1.5× 724 0.5× 333 0.5× 507 0.9× 195 0.5× 320 6.6k
Fritz Krombach Germany 37 993 0.5× 1.1k 0.7× 381 0.6× 143 0.2× 281 0.7× 76 4.0k
Takeshi Fujii Japan 45 2.0k 1.0× 623 0.4× 1.3k 2.1× 239 0.4× 500 1.2× 359 7.7k

Countries citing papers authored by Mark David

Since Specialization
Citations

This map shows the geographic impact of Mark David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark David more than expected).

Fields of papers citing papers by Mark David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark David. The network helps show where Mark David may publish in the future.

Co-authorship network of co-authors of Mark David

This figure shows the co-authorship network connecting the top 25 collaborators of Mark David. A scholar is included among the top collaborators of Mark David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark David. Mark David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Danqing, Zhiheng Xu, Li Han, et al.. (2016). Identification of New ATG4B Inhibitors Based on a Novel High-Throughput Screening Platform. SLAS DISCOVERY. 22(4). 338–347. 27 indexed citations
2.
David, Mark, et al.. (2014). Mobile phones in clinical practice: Reducing the risk of bacterial contamination. International Journal of Surgery. 12. S14–S14. 9 indexed citations
3.
Wartchow, Charles, Frank Podlaski, Shirley Xin Li, et al.. (2011). Biosensor-based small molecule fragment screening with biolayer interferometry. Journal of Computer-Aided Molecular Design. 25(7). 669–676. 107 indexed citations
4.
Bard, Delphine, et al.. (2009). Current standardisation for nanotechnology. Journal of Physics Conference Series. 170. 12036–12036. 2 indexed citations
5.
Olivieri, Kevin C., Aprille L. Matthews, Mark David, et al.. (2006). The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. Virology. 358(1). 23–38. 22 indexed citations
6.
Harrison, Roy M., et al.. (2001). Studies of the coarse particle (2.5–10μm) component in UK urban atmospheres. Atmospheric Environment. 35(21). 3667–3679. 197 indexed citations
7.
Motamedi, Haideh, et al.. (2000). A High-Throughput Assay to Identify Compounds That Can Induce Dimerization of the Erythropoietin Receptor. Analytical Biochemistry. 278(1). 39–45. 4 indexed citations
8.
Shi, Ji Ping, Mark David, & Roy M. Harrison. (2000). Characterization of Particles from a Current Technology Heavy-Duty Diesel Engine. Environmental Science & Technology. 34(5). 748–755. 164 indexed citations
9.
Qureshi, Sajjad A., Ronald M. Kim, Zenon Konteatis, et al.. (1999). Mimicry of erythropoietin by a nonpeptide molecule. Proceedings of the National Academy of Sciences. 96(21). 12156–12161. 81 indexed citations
10.
David, Mark, et al.. (1995). Characterization of Protein Complexes Formed on the Repressor Elements of the Human Tumor Necrosis Factor α Gene. Journal of Interferon & Cytokine Research. 15(10). 887–895. 12 indexed citations
11.
Wu, Tsuei-Ju, et al.. (1994). Transcriptional Activation by Herpes Simplex Virus Type 1 VP 16 In Vitro and Its Inhibition by Oligopeptides. Molecular and Cellular Biology. 14(5). 3484–3493. 18 indexed citations
12.
David, Mark, et al.. (1994). Identification and characterization of a novel repressor site in the human tumor necrosis factor α gene. Nucleic Acids Research. 22(6). 1108–1114. 76 indexed citations
13.
Rappolee, Daniel A., Alice Wang, Mark David, & Zena Werb. (1989). Novel method for studying mRNA phenotypes in single or small numbers of cells. Journal of Cellular Biochemistry. 39(1). 1–11. 332 indexed citations
14.
Vu, Thiennu H., Gail R. Martin, Pauline Lee, et al.. (1989). Developmentally Regulated Use of Alternative Promoters Creates a Novel Platelet-Derived Growth Factor Receptor Transcript in Mouse Teratocarcinoma and Embryonic Stem Cells. Molecular and Cellular Biology. 9(10). 4563–4567. 12 indexed citations
16.
Rappolee, Daniel A., Mark David, Michael J. Banda, & Zena Werb. (1988). Wound Macrophages Express TGF-α and Other Growth Factors in Vivo: Analysis by mRNA Phenotyping. Science. 241(4866). 708–712. 925 indexed citations breakdown →
17.
David, Mark, Alice Wang, & Corey Levenson. (1987). [21] Site-specific mutagenesis to modify the human tumor necrosis factor gene. Methods in enzymology on CD-ROM/Methods in enzymology. 154. 403–414. 8 indexed citations
18.
Kawasaki, Ernest S., Martha Ladner, Alice M. Wang, et al.. (1985). Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1). Science. 230(4723). 291–296. 440 indexed citations
19.
Wang, Alice M., Abla A. Creasey, Martha Ladner, et al.. (1985). Molecular Cloning of the Complementary DNA for Human Tumor Necrosis Factor. Science. 228(4696). 149–154. 547 indexed citations breakdown →
20.
Rosenberg, Steven A., Elizabeth A. Grimm, Michael McGrogan, et al.. (1984). Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli. Science. 223(4643). 1412–1415. 525 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026